Home › Funds › NAN FUNG TRINITY (HK) Ltd › TRVI

NAN FUNG TRINITY (HK) Ltd position in TRVI

TREVI THERAPEUTICS INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 1,082,890 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 1.49% of its reported portfolio and ranking #26 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.08M sh
Reported value held$15.51M
Portfolio Weight1.49%
First reportedQ3 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's TRVI position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in TRVI in Q3 2025 at 89,575 shares (US$820K). The position peaked in Q2 2026 at 1,213,620 shares, worth US$22.6M. Across 5 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,082,890 shares valued at US$15.5M — a reduction of -130,730 shares quarter over quarter.. Notable position changes include a 924% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 89.58K $819.61K New
Q4 2025 917.45K $11.49M Add
Q1 2026 1.14M $13.64M Add
Q2 2026 1.21M $22.63M Add
Q3 2026 1.08M $15.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$60.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held TRVI?

NAN FUNG TRINITY (HK) Ltd has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in TRVI?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 1.08M shares of TRVI (TREVI THERAPEUTICS INC), valued at $15.51M, representing 1.49% of its reported portfolio and ranking #26.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling TRVI?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd reduced its position in TRVI. The position peaked in Q2 2026 at 1.21M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.